1dfp: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Factor D (D) is a serine protease, crucial for the activation of the, alternative complement pathway. Only a limited number of general serine, protease inhibitors are known to inhibit D, most of which covalently bind, to the serine hydroxyl of the catalytic triad. The structure of the first, enzyme:inhibitor covalent adduct of D with diisopropyl fluorophosphate, (DIP:D) to a resolution of 2.4 A is described. The inhibited enzyme is, similar in overall structure to the native enzyme and to trypsin, yet, exhibits notable differences in the active site. One region of the active, site is conserved between D and trypsin with respect to amino-acid, sequence and to conformation. Another reflects the amino-acid, substitutions and conformational flexibility between these enzymes. The, active-site histidine residue is observed in the gauche+ conformation, not, the normal gauche- orientation seen in the classic catalytic triad, arrangement required for enzymatic activity in serine proteases., Comparisons of the active sites between native D, the DIP:D adduct, and, DIP-inhibited trypsin have provided fundamental insights currently being, employed in the design of novel small-molecule pharmaceutical agents, capable of modulating the alternative complement pathway.
Factor D (D) is a serine protease, crucial for the activation of the alternative complement pathway. Only a limited number of general serine protease inhibitors are known to inhibit D, most of which covalently bind to the serine hydroxyl of the catalytic triad. The structure of the first enzyme:inhibitor covalent adduct of D with diisopropyl fluorophosphate (DIP:D) to a resolution of 2.4 A is described. The inhibited enzyme is similar in overall structure to the native enzyme and to trypsin, yet exhibits notable differences in the active site. One region of the active site is conserved between D and trypsin with respect to amino-acid sequence and to conformation. Another reflects the amino-acid substitutions and conformational flexibility between these enzymes. The active-site histidine residue is observed in the gauche+ conformation, not the normal gauche- orientation seen in the classic catalytic triad arrangement required for enzymatic activity in serine proteases. Comparisons of the active sites between native D, the DIP:D adduct, and DIP-inhibited trypsin have provided fundamental insights currently being employed in the design of novel small-molecule pharmaceutical agents capable of modulating the alternative complement pathway.


==Disease==
==Disease==
Line 17: Line 17:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Babu, Y.S.]]
[[Category: Babu, Y S.]]
[[Category: Chu, N.]]
[[Category: Chu, N.]]
[[Category: Cole, L.B.]]
[[Category: Cole, L B.]]
[[Category: Kilpatrick, J.M.]]
[[Category: Kilpatrick, J M.]]
[[Category: Narayana, S.V.L.]]
[[Category: Narayana, S V.L.]]
[[Category: Volanakis, J.E.]]
[[Category: Volanakis, J E.]]
[[Category: DFP]]
[[Category: DFP]]
[[Category: complement]]
[[Category: complement]]
Line 29: Line 29:
[[Category: serine protease]]
[[Category: serine protease]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 09:35:30 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:16:11 2008''

Revision as of 13:16, 21 February 2008

File:1dfp.jpg


1dfp, resolution 2.4Å

Drag the structure with the mouse to rotate

FACTOR D INHIBITED BY DIISOPROPYL FLUOROPHOSPHATE

OverviewOverview

Factor D (D) is a serine protease, crucial for the activation of the alternative complement pathway. Only a limited number of general serine protease inhibitors are known to inhibit D, most of which covalently bind to the serine hydroxyl of the catalytic triad. The structure of the first enzyme:inhibitor covalent adduct of D with diisopropyl fluorophosphate (DIP:D) to a resolution of 2.4 A is described. The inhibited enzyme is similar in overall structure to the native enzyme and to trypsin, yet exhibits notable differences in the active site. One region of the active site is conserved between D and trypsin with respect to amino-acid sequence and to conformation. Another reflects the amino-acid substitutions and conformational flexibility between these enzymes. The active-site histidine residue is observed in the gauche+ conformation, not the normal gauche- orientation seen in the classic catalytic triad arrangement required for enzymatic activity in serine proteases. Comparisons of the active sites between native D, the DIP:D adduct, and DIP-inhibited trypsin have provided fundamental insights currently being employed in the design of novel small-molecule pharmaceutical agents capable of modulating the alternative complement pathway.

DiseaseDisease

Known diseases associated with this structure: Azoospermia OMIM:[400005], Complement factor D deficiency OMIM:[134350], Corneal fleck dystrophy OMIM:[609414], Properdin deficiency, X-linked OMIM:[300383]

About this StructureAbout this Structure

1DFP is a Single protein structure of sequence from Homo sapiens with as ligand. Active as Complement factor D, with EC number 3.4.21.46 Known structural/functional Sites: and . Full crystallographic information is available from OCA.

ReferenceReference

Structure of diisopropyl fluorophosphate-inhibited factor D., Cole LB, Chu N, Kilpatrick JM, Volanakis JE, Narayana SV, Babu YS, Acta Crystallogr D Biol Crystallogr. 1997 Mar 1;53(Pt 2):143-50. PMID:15299948

Page seeded by OCA on Thu Feb 21 12:16:11 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA